Priya Kathpalia, MD
Gastroenterology · San Francisco, CANPI 1194046821
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.1%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 58.1% of the total. 2025 is the largest year on record at $3,894, more than ten times the $213 reported in 2019.
Across 18 payments — averaging $389.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$4K
- Phathom Pharmaceuticals, Inc.$2K
- Medtronic$250
- AbbVie$183
- Boston Scientific$77
- Pentax Of America, Inc.$25
Across 4 payments — averaging $22,373 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi$89K
What the payments were for
- Consulting fees$3,86155%
- Speaking & faculty fees$2,40034%
- Travel & lodging$401%
- Food & beverage$70710%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 7 | $4,073 |
| Phathom Pharmaceuticals, Inc. | 1 | $2,400 |
| Medtronic | 4 | $250 |
| AbbVie(2 entities) | 4 | $183 |
| Boston Scientific | 1 | $77 |
| Pentax Of America, Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,008 in reported general payments places this provider in the 75th percentile of 1,885 gastroenterology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Esomeprazole Magnesium | 20 | $1,712 |
| Omeprazole | 69 | $1,419 |
| Famotidine | 37 | $372 |
| Pantoprazole Sodium | 11 | $96 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in San Francisco
- Kenneth BinmoellerSan Francisco$507K
- Uma MahadevanSan Francisco$325K
- Francis YaoSan Francisco$159K
- Bennett RothLos Angeles$2.8M
- Douglas NguyenMission Viejo$2M
- Sammy SaabLos Angeles$1.9M
- Kenneth ChangNewport Beach$1.3M
- Joo HwangStanford$1M
- Drew SchembreWalnut Creek$659K
- Quan Nhula Jolla$641K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.